Dorsey Wright & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Sell
2,862
-8,363
-75% -$979K 0.06% 112
2026
Q1
$1.35M Buy
+11,225
New +$1.3M 0.17% 110
2024
Q1
– Sell
-2,198
Closed -$240K – 139
2023
Q4
$240K Hold
2,198
– – 0.07% 126
2023
Q3
$226K Buy
2,198
+18
+0.8% +$1.94K 0.07% 124
2023
Q2
$252K Buy
+2,180
New +$248K 0.08% 121

Other funds holding MRK

Dorsey Wright & Associates's MRK Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its Merck (MRK) stake by 75% in Q2 2026, selling an estimated $979K and leaving 2,862 shares worth $368K. The position accounts for 0.06% of the portfolio, ranked #112.

Dorsey Wright & Associates first reported a position in MRK in Q2 2023 and has held it in 5 quarters since. The position peaked at $1.35M in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Dorsey Wright & Associates held 2,862 shares of Merck worth $368K as of Q2 2026.
  • Dorsey Wright & Associates sold 8,363 Merck shares in Q2 2026, an estimated $979K.
  • Merck made up 0.06% of Dorsey Wright & Associates's portfolio in Q2 2026, its #112 holding.
  • Dorsey Wright & Associates first reported a position in Merck in Q2 2023 and has held it in 5 quarters since.
  • Dorsey Wright & Associates's Merck position peaked at $1.35M in Q1 2026.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.